Valeant price target raised to $20 from $17 at BMO Capital BMO Capital analyst Gary Nachman raised his price target on Valeant to $20 from $17 and raised his EPS, EBITDA, and revenue estimates on the stock after Valeant reported "solid" Q1 earnings that beat BMO and consensus estimates, as well as raising its FY18 EBITDA and revenue guidance. Nachman maintained a Market Perform rating on Valeant shares although there "are still some questions about sustainability of certain revenue drivers and potential contribution from key new product launches